MesteroloneThird Party Manufacturing in India

Mesterolone is a synthetic androgen and anabolic steroid derived from dihydrotestosterone, characterised by a 1-alpha-methyl group that prevents its metabolism to estrogenic compounds. It works by binding directly to the androgen receptor in target tissues, including the prostate, seminal vesicles, testes, skeletal muscle, and brain. Upon binding, the androgen-receptor complex translocates to the nucleus and interacts with androgen response elements on DNA, regulating the transcription of genes involved in male sexual development, spermatogenesis, nitrogen retention, and protein synthesis. Unlike testosterone, Mesterolone is not aromatised to estradiol because the 1-alpha-methyl group sterically hinders the aromatase enzyme, meaning it produces no estrogenic side effects such as gynaecomastia or fluid retention. It is also not 5-alpha-reduced since it already resembles dihydrotestosterone, giving it a direct and potent androgenic effect in target tissues. Mesterolone exerts negative feedback on the hypothalamic-pituitary-gonadal axis, reducing luteinising hormone and follicle-stimulating hormone secretion, which can suppress endogenous testosterone production. Its oral bioavailability is improved by the 1-alpha-methyl modification, allowing convenient oral administration compared to injectable testosterone preparations. The drug has a relatively mild anabolic-to-androgenic ratio, making it suitable for androgen replacement therapy where moderate androgenic effect is desired.

Therapeutic Uses

Mesterolone is prescribed for the treatment of:

• Male hypogonadism: As androgen replacement therapy in men with low testosterone levels, particularly when preservation of fertility is desired since it does not fully suppress spermatogenesis.
• Male infertility associated with oligospermia: Used to improve sperm count and quality in selected cases of idiopathic male infertility.
• Androgen deficiency symptoms: Relieves symptoms such as reduced libido, erectile dysfunction, fatigue, and loss of muscle mass in men with confirmed low testosterone.
• Delayed puberty in boys: Stimulates development of secondary sexual characteristics when physiological puberty is delayed.

Why Manufacturers Choose Mesterolone

Mesterolone occupies a niche position in the androgen market as an oral androgen with no estrogenic conversion, making it a preferred choice for physicians who wish to avoid gynaecomastia and fluid retention associated with other androgen therapies. The molecule is off-patent with established manufacturing processes and stable API supply from Indian and Chinese sources. It is available in 25 mg tablets, a standard strength that simplifies inventory management. Demand is consistent from endocrinology and urology practices, and the drug is listed in several national formularies. Indian manufacturers benefit from growing awareness of male hypogonadism and increasing treatment rates in both domestic and Middle Eastern markets. This makes Mesterolone one of the most sought-after molecules for third party manufacturing in India, with consistent demand from PCD franchise operators and export-oriented companies.